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Abstract
Polycystic ovary syndrome (PCOS) is a complex but frequently occurring endocrine abnormality.
PCOS has become one of the leading causes of oligo-ovulatory infertility among premenopausal
women. The definition of PCOS remains unclear because of the heterogeneity of this abnormality,
but it is associated with insulin resistance, hyperandrogenism, obesity and dyslipidaemia. The main
purpose of this study was to identify possible candidate genes involved in PCOS. Several genomic
approaches, including linkage analysis and microarray analysis, have been used to look for candidate
PCOS genes. To obtain a clearer view of the mechanism of PCOS, we have compiled data from
microarray analyses. An extensive literature search identified seven published microarray analyses
that utilized PCOS samples. These were published between the year of 2003 and 2007 and included
analyses of ovary tissues as well as whole ovaries and theca cells. Although somewhat different
methods were used, all the studies employed cDNA microarrays to compare the gene expression
patterns of PCOS patients with those of healthy controls. These analyses identified more than a
thousand genes whose expression was altered in PCOS patients. Most of the genes were found to
be involved in gene and protein expression, cell signaling and metabolism. We have classified all of
the 1081 identified genes as coding for either known or unknown proteins. Cytoscape 2.6.1 was
used to build a network of protein and then to analyze it. This protein network consists of 504
protein nodes and 1408 interactions among those proteins. One hypothetical protein in the PCOS
network was postulated to be involved in the cell cycle. BiNGO was used to identify the three main
ontologies in the protein network: molecular functions, biological processes and cellular
components. This gene ontology analysis identified a number of ontologies and genes likely to be
involved in the complex mechanism of PCOS. These include the insulin receptor signaling pathway,
steroid biosynthesis, and the regulation of gonadotropin secretion among others.
Background
Stein and Leventhal pioneered the study of Polycystic
Ovary Syndrome (PCOS) in 1935 when they identified
the abnormality in a small group of women with amenor-
rhea, hirsutism, obesity and histological evidence of poly-
cystic ovaries [1]. Today, PCOS is a common endocrine
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age [2]. There is no universal definition for this heteroge-
neous endocrine disorder [2]. However, during the 2003
Rotterdam Consensus workshop, PCOS was defined as a
multi-system network of abnormalities that includes
obesity, insulin resistance, hyperandrogenism, elevated
luteinizing hormone (LH) concentrations, increased risk
of type 2 diabetes mellitus, cardiovascular events and
menstrual irregularities [3]. Insulin resistance is found in
up to 70% of women with PCOS and 80% of the PCOS
patients are hyperandrogenemic [4]. Several pathways are
thought to be involved in PCOS, and these include steroid
hormone synthesis [5,6], the insulin-signaling pathway
[7] and gonadotrophin hormone action [8]. Mutation
analyses, linkage studies and case-control association
studies have been used to assess the roles of candidate
genes from these pathways in PCOS [9]. CYP11A is a ster-
oid synthesis gene that was found to be associated with
PCOS and serum testosterone levels by a genetic polymor-
phism study [5]. A linkage analysis using PCOS patients
revealed the involvement of a 5' region of the insulin gene
that contains a variable number of tandem repeats
(VNTRs) [10]. However, none of those genes are likely to
be the key players in the pathogenesis of PCOS because its
complexity and heterogeneity suggest the involvement of
many genes as well as environmental factors [4,9].
Another genomic technique that has been widely used to
investigate the mechanism of PCOS and to identify candi-
date PCOS genes is the microarray-based comparison of
ovarian tissues (theca cells, follicular granulose cells, total
ovarian tissue, and ovarian connective tissue) from PCOS
patients with ovarian tissues from healthy controls [4].
The first PCOS microarray study was published by Wood
and colleagues in 2003 [11]. They used theca cells from
PCOS women and healthy controls as their samples and
identified 244 differentially expressed genes. Their find-
ings on the upregulation of GATA-6, which is involved in
the transcription of CYP11A supported earlier linkage
analyses [5]. Several other microarray analyses have
helped shed light on the pathophysiology of PCOS. These
results contributed to the dataset used in this study. The
goal of this study was to obtain a clearer view of the mech-
anism of PCOS, since the definition of the abnormality
remains unclear. Therefore we collated information on
proteins related to PCOS, constructed a hypothetical net-
work of interactions among PCOS-related proteins, and
then inferred the function of a hypothetical protein that
may be involved in PCOS.
Methods
A number of previous studies, including mutation analy-
ses, linkage studies and case-control association studies
have identified 58 candidate PCOS genes [9]. In order to
identify more proteins that may be related to PCOS,
results from microarray analyses were used as a dataset in
this study. These results were gathered from a literature
search of various literature databases such as ScienceDi-
rect http://www.sciencedirect.com and PubMed http://
www.ncbi.nih.gov/pubmed/ among others. Candidate
proteins were then classified manually as either known
proteins or hypothetical proteins. The sequences of the
hypothetical proteins were analyzed in detail to shed light
on their functions. BLAST http://blast.ncbi.nlm.nih.gov/
Blast.cgi was used to run similarity searches on the hypo-
thetical proteins to infer functional and evolutionary rela-
tionships between protein sequences. To gain further
functional information, InterProScan http://
www.ebi.ac.uk/InterProScan was used to search the pro-
tein sequences for motifs characteristic of previously
described domains and protein families. Moreover, PRO-
SCAN http://npsa-pbil.ibcp.fr/cgi-bin/
npsa_automat.pl?page=/NPSA/npsa_proscan.html was
used to scan the protein sequences for sites and/or signa-
tures contained in the PROSITE database. This tool is used
to identify biologically relevant sites, patterns and profiles
in a protein sequences.
All of the proteins identified by these methods were com-
bined with the 58 PCOS-related proteins identified from
the literature review. These proteins were then loaded into
Cytoscape 2.6.1 [12] using the BioNetBuilder plugin. Bio-
NetBuilder 2.0 [13] is an open-source network visualiza-
tion platform. BioNetBuilder uses a variety of databases
that include DIP (Database of Interacting Proteins), BIND
(Biomolecular Interaction Network Database), HPRD
(Human Protein Reference Database), KEGG (Kyoto
Encyclopedia of Genes and Genomes) and MINT (Molec-
ular Interaction Database) among others. However, since
our study involves only proteins found in humans, only
four databases were used: KEGG, HPRD, BIND and MINT.
All of the collated proteins have their own UniProt ID and
these were used as input for BioNetBuilder 2.0. Pathway
construction with BioNetBuilder 2.0 usually takes several
minutes depending on the amount of input loaded as well
as the internet server used. BiNGO [14] was used to ana-
lyze the gene ontology in the PCOS network.
Results and Discussion
Seven microarray analyses were identified in the scientific
literature published between 2003 and 2007. The first
paper was published by Wood and colleagues, who stud-
ied theca cells isolated from average-sized follicles of the
ovaries of PCOS patients and normal women [11]. This
same group conducted a similar study in 2004 but used
theca cells treated with valproic acid (VPA) in order to
assess the involvement of VPA with PCOS [15]. In the
same year, two different PCOS microarray studies were
published [16,17]. In 2005, scientists from Finland used
cDNA microarrays to identify differentially expressedPage 2 of 7
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study, published in 2007 by two different research groups,
used two types of samples; omental adipose tissue [19]
and oocyte samples [20] taken from PCOS patients. All of
the differentially expressed genes identified by these
microarray analyses are listed in Table 1. The differentially
expressed genes were then identified and thoroughly ana-
lyzed. Any overlapping genes involved in more than one
microarray study were unified. Moreover, the identified
genes were compared with protein databases such as Uni-
Prot to gather their biological information such as their
origin, function, domain and protein family, the ontology
involved, their interactions and pathways as well as other
information on their 3D structure that have been experi-
mentally determined [21]. Thus, the overall number of
genes was reduced and the remainders were classified as
either known proteins or hypothetical proteins. The total
number of proteins identified was 1081, and these con-
sisted of 1066 known proteins and 15 hypothetical pro-
teins. These proteins comprised the dataset used in the
remainder of the study.
Sequence analyses were conducted to infer the function of
each hypothetical protein. These analyses yielded numer-
ous results. However, BLASTP analysis failed to identify
any important functional or evolutionary relationship
between the hypothetical proteins and known proteins.
Moreover, most of the hypothetical proteins did not have
any recognizable domains or protein family signatures in
their sequences. Only one hypothetical protein
(KIAA0247) had domain, family and superfamily associ-
ations in its protein sequence. The domain recognized is a
sushi domain, also known as a complement control pro-
tein (CCP) module or short consensus repeat (SCR). Most
of the hypothetical proteins contain casein kinase II phos-
phorylation sites and protein kinase C phosphorylation
sites. Casein kinase II (CK-2) is a serine/threonine protein
kinase whose activity is independent of cyclic nucleotides
and calcium. CK-2 phosphorylates many different pro-
teins. This pattern is found in most of its known physio-
logical substrates [22]. Protein kinase C preferentially
phosphorylates serine and threonine residues that are
near C-terminal basic residues. The presence of additional
basic residues at the N- or C-terminus of the target amino
acid enhances the Vmax and Km of the phosphorylation
reaction [23].
Several differentially expressed genes that were identified
in more than one microarray analysis were chosen to be
analyzed in detail in the protein network. The alpha actin
2 protein was found to be downregulated both by the
The hypothetical PCOS pathway assembled by BioNet-Builder 2.0 in Cytoscape 2.6.1Figure 1
The hypothetical PCOS pathway assembled by Bio-
NetBuilder 2.0 in Cytoscape 2.6.1. From the 1081 input 
genes, only 504 protein nodes and 1408 interactions among 
those proteins were assembled. Protein-protein interactions 
identified by the HPRD database (712) are represented in 
red. Interactions identified by the KEGG database (561) are 
represented in blue. Interactions from the MINT database 
(68) are represented in yellow. Interactions from the BIND 
database (67) are represented in green.
Table 1: Microarray analyses of PCOS samples from 2003 to 2007
Microarray study Number of differentially expressed genes
The molecular phenotype of PCOS theca cells and new candidate genes defined by microarray 
analysis [11]
244
Valproate-induced alteration in human theca cell gene expression [15] 199
Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome [16] 135
The molecular characteristics of PCOS defined by human ovary cDNA microarray [17] 119
Molecular profiling of polycystic ovaries for markers of cell invasion and matrix turnover [18] 44
Differential gene expression profile in omental adipose tissue in women with PCOS [19] 63
Molecular abnormalities in oocytes from women with PCOS revealed by microarray analysis [20] 374
TOTAL 1178Page 3 of 7
(page number not for citation purposes)
Theoretical Biology and Medical Modelling 2009, 6:18 http://www.tbiomed.com/content/6/1/18Wood group in 2003 and by the Cortón group in 2007.
Actins are usually involved in cell motility and are ubiqui-
tously expressed in all eukaryotic cells. The HPRD data-
base linked ACTA2 with SHBG, which is a protein
frequently identified in linkage analyses of PCOS. SHBG
expression tends to be reduced in PCOS patients due to
their elevated insulin levels. Thus, decreased levels of
alpha actin will lead to a reduced level of SHBG, which in
turn increases the bioavailability of androgens [24], a fea-
ture of PCOS. A PCOS network was constructed with the
BioNetBuilder 2.0 plugin in Cytoscape 2.6.1. The UniProt
accession numbers of each protein from the dataset were
used as input for the construction of the PCOS network.
From the list of 1081 genes loaded into Cytoscape, 504
protein nodes and 1408 protein interactions were assem-
bled and visualized. The interactions among those pro-
teins were determined with the aid of four protein-protein
interaction databases, including HPRD (Human Protein
Reference Database), KEGG (Kyoto Encyclopedia of
Genes and Genomes), BIND (Biomolecular Interaction
Network Database) and MINT (Molecular Interaction
Database). Figure 1 shows the resulting PCOS protein net-
work. This network predicted that one of the PCOS hypo-
thetical proteins, which is LOC54987 interacts with a
cyclin (Figure 2). Like aurora kinase and actin binding
protein, cyclin B1 is an APC (anaphase promoting com-
plex) substrate [25]. APC is a key cell cycle regulator that
both initiates anaphase and regulates mitotic exit [26].
Further analysis conducted on this hypothetical protein
(LOC54987) shown the existence of a signal peptide
region that cleaved at amino acid position of 19. A signal
peptide on a protein indicates that this protein is destined
either to be secreted or to be a membrane component.
LOC54987 is a single-domain protein; identified as DUF
domain (DUF866, PF05907). It is categorized into a
group of hypothetical eukaryotic proteins of unknown
function; where one member in this group has been deter-
mined its 3D structure (1ZSO, Plasmodium falciparum
MAL13P1.257) [27] and share 25.9% identity with
LOC54987. LOC 54987 is a conserved hypothetical pro-
tein with two CXXC motifs strongly conserved in all other
family members. LOC54987 is also known as chromo-
some 1 ORF123, and is found differentially expressed in
PCOS oocytes [20], but unfortunately there is no evidence
that this sequence has been isolated. Based on our pre-
dicted PCOS protein-protein interaction network,
Protein-protein interactions of the hypothetical proteinFigure 2
Protein-protein interactions of the hypothetical protein. The HPRD database identified an interaction between the 
hypothetical protein and cyclin B1. Cyclin B1 interacts with 9 other proteins including geminin, the tumor suppressor protein 
p53, and cyclin-dependent kinase 6 among others.Page 4 of 7
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in the cell cycle, B type cyclins are usually present during
the G2 exit and mitosis phase. Cyclin B1 also associates
with CDK1 [28], forms complexes that regulate a number
of processes during the G2 exit [29], and also involves in
the progression through mitosis [30]. Cyclin B1 is a major
regulator in mammalian mitosis whereby the inhibition
of cyclin B1 transcription by the p53 tumor suppressor
may inhibit the G2/M transition in human cells [31],
which supported the interaction of cyclin B1-p53 in this
Molecular function mapFigure 3
Molecular function map. Map of molecular functions associated with PCOS. Darker nodes refer to the significant ontolo-
gies of the dataset. The size is proportional to the number of genes that participate in that molecular function.Page 5 of 7
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involved in cell cycle regulation are Gadd45 (growth
arrest and DNA-damage-inducible) alpha and beta, gemi-
nin, proliferating cell nuclear antigen, CDK6, and S-phase
kinase associated protein 1 isoform a; whilst SET translo-
cation (myeloid leukemia-associated) is a multitasking
protein which involved in apoptosis, transcription, nucle-
osome assembly and histone binding; and v-akt murine
thymona viral oncogene homolog 1 is type of AKT that is
capable of phosphorylating several known proteins.
Based on this predicted interaction, LOC54987 can be
identified as a new protein that functions as a cell-cycle
regulator, due to its direct interaction with cyclin B1. As
other proteins are widely studied, thus it is very interesting
to further analyze LOC54987 experimentally to have
detailed understanding on the protein itself and also to
validate this predicted interaction.
The PCOS network was then analyzed with the Biological
Networks Gene Ontology (BiNGO) program to identify
ontologies involved in the protein network. BiNGO is one
of the plugins for Cytoscape 2.6.1. Three ontologies (cel-
lular component, molecular function and biological proc-
ess) were identified in the BiNGO analysis. Figure 3 shows
the results from the BiNGO analysis regarding molecular
function. The binding node is the most significant node as
it involves 415 of the 468 proteins. The binding node
encompasses multiple types of molecular interactions,
including protein binding, nucleic acid binding, peptide
binding, pattern binding, carbohydrate binding and
nucleotide binding. Detailed results are displayed in Fig-
ure 4. Other molecular function nodes that may play an
important role in the pathogenesis of PCOS include ster-
oid dehydrogenase activity (12 genes) and estradiol 17-
beta-dehydrogenase activity (5 genes), among others. The
molecular function mode of BiNGO identified three
genes (INHBA, ACVR1 and ACVR2A) involved in follista-
tin binding. Follistatin was also implicated in PCOS by
linkage analysis [9]. BiNGO identified several biological
processes that maybe involved with PCOS including lipid
metabolism (40 genes), regulation of apoptosis (56
genes), insulin receptor signaling (9 genes), steroid bio-
synthesis (13 genes) and the regulation of gonadotropin
secretion (3 genes). Of the 473 genes in biological process
genes identified by BiNGO, 40 were involved with lipid
metabolism. One of these genes, ALOX15, is a lipoxygen-
ase that was found to be upregulated in omental fat of
PCOS patients [19]. ALOX15 may be involved with insu-
lin resistance since a number of lypoxygenase-oxidized
fatty acids become leukotrienes, which contribute to the
chronic inflammatory condition of PCOS [19]. Labora-
tory findings support this idea as the inhibition of lipoxy-
genases was found to enhance the action of insulin in rat
models of insulin resistance and type 2 diabetes [32].
Conclusion
Information from genomic analysis is ideally suited to
elucidating the mechanism of complex syndrome such as
PCOS. Therefore, we constructed a dataset composed of
information from microarray analyses and other genomic
studies of PCOS patients. This dataset, which consists of
1081 candidate genes, was used to construct a PCOS net-
work. This network contains 504 protein nodes and 1408
interactions between those proteins. The network pre-
dicted that a hypothetical protein whose function was pre-
viously unknown interacts with cyclin B1. Thus this
hypothetical protein may be involved in the cell cycle. The
network also identified a number of molecular functions
and biological processes likely to be involved in PCOS.
These include steroid dehydrogenase activity, estradiol
17-beta-dehydrogenase activity, lipid metabolism, regula-
tion of apoptosis, the insulin receptor signaling pathway,
steroid biosynthesis and the regulation of gonadotropin
secretion. The genes involved in these molecular func-
tions and biological processes were then categorized as
genes likely to have important roles in the mechanism of
PCOS.
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Protein binding nodeFigure 4
Protein binding node. The protein binding node is con-
nected to 12 other nodes. The protein binding node is the 
most significant node because it encompasses 331 genes. Of 
the 468 genes in the PCOS molecular function network, 339 
(72.4%) are involved in protein binding and are thereby 
linked to other protein nodes such as the transcription fac-
tors (34 genes), identical proteins (37 genes), protein dimeri-
zation (35 genes), receptors (50 genes), protein complexes 
(13 genes), cyclins (2 genes), enzymes (24 genes), growth fac-
tors (13 genes), follistatins (3 genes), and insulin receptor 
substrates (3 genes).Page 6 of 7
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